Home / news / EDA Chairman Visits Wadi El Nile Ashito Pharmaceuticals Factory

EDA Chairman Visits Wadi El Nile Ashito Pharmaceuticals Factory

Businessmen Team news 19 September 2025 04:34 PM
Share Article:
EDA Chairman Visits Wadi El Nile Ashito Pharmaceuticals Factory

Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), visited Wadi El-Nile Ashito Pharmaceuticals as part of the authority’s efforts to strengthen strategic partnerships and expand cooperation with leading players in the medical products and supplies sector.

The visit included a review of the factory’s achievements in manufacturing dialysis supplies in line with the highest local and international standards. Discussions also addressed ways to enhance cooperation to support and develop the healthcare sector in Egypt. This comes in line with the state’s vision to improve service quality and ensure access to the latest medical solutions and technologies for both patients and healthcare professionals.

El-Ghamrawy reaffirmed the EDA’s commitment to supporting local investment in medical supplies. He explained that the authority is working continuously to streamline and complete regulatory procedures. These efforts aim to create an attractive investment climate and ensure wider availability of advanced medical devices and products in the Egyptian market.

He stressed that ensuring the sustainable availability of high-quality dialysis supplies is a top priority for the authority. He added that this directly contributes to meeting patients’ needs and strengthening the healthcare system.

Officials from Wadi El-Nile Ashito Pharmaceuticals praised the pivotal role played by the EDA in supporting the medical supplies industry, especially in the field of dialysis. They confirmed that the authority’s efforts in facilitating procedures and providing a flexible regulatory environment have significantly enhanced the factory’s capabilities. This has also helped improve product quality in line with international standards, ensuring patients’ needs are met and healthcare services are upgraded.

The EDA delegation included Dr. Amani Gawdat, Assistant to the Chairman and Supervisor of the Central Administration of the Chairman’s Office; Dr. Osama Hatem, Assistant to the Chairman and Supervisor of the Central Administration for Pharmaceutical Policies and Market Support; Dr. Mohab Fady, Head of the Central Administration for Pharmaceutical Institutions Licensing; and Dr. Doaa Mahrous, Director General of the Medical Supplies Registration Department.

Representing the factory were Counselor Dr. Amr Abdel Razek, Chairman of the Board; Major General Mohamed Dabour, Vice Chairman; and Dr. Mostafa Fawzy Abdel Baky, Executive Director and Factory Manager.

This visit reflects the EDA’s commitment to supporting innovation and development in healthcare. The authority is working to provide a flexible and effective regulatory infrastructure that ensures the rapid delivery of advanced medical supplies to patients in need. These efforts positively impact citizens’ health and contribute to improving the quality of healthcare services in Egypt.